RNA-based therapies have catalyzed a revolutionary transformation in the biomedical
landscape, offering unprecedented potential in disease prevention and treatment. However …

Aptamers are short single-stranded DNA or RNA oligonucleotides isolated from randomized
libraries, presenting high affinity and specificity toward targets with similar to antibodies …

Novel treatment approaches are needed to overcome innate and acquired mechanisms of
resistance to current anticancer therapies in cancer cells and the tumour immune …

Fluorescent probes that emit in the far-red (600–700 nm), first near-infrared (NIR-I, 700–900
nm), and second NIR (NIR-II, 900–1700 nm) regions possess unique advantages, including …

Aptamers are single-stranded oligonucleotides that bind to their targets via specific structural
interactions. To improve the properties and performance of aptamers, modified nucleotides …

Radio-immunotherapy exploits the immunostimulatory features of ionizing radiation (IR) to
enhance antitumor effects and offers emerging opportunities for treating invasive tumor …

A wide variety of nanomaterials have emerged in recent years with advantageous properties
for a plethora of therapeutic and diagnostic applications. Such applications include drug …

Chemiluminescence (CL) sensing with good performance remains a challenge. The
utilization of secondary residues from polyvinyl chloride (PVC) treatment is the key to …

Functionally modified aptamer conjugates are promising tools for targeted imaging or
treatment of various diseases. However, broad applications of aptamer molecules are …

Aptamers are chemical antibodies possessing the capability of overcoming the limitations
posed by conventional antibodies, particularly for diagnostic, therapeutic, and theranostic …